Category Archives: Cost of healthcare in the U.S.

Drug pricing and pharma: untold truths

KEY TAKEAWAY:  Pharma stocks lost over $24 billion in value after Mr Trump said drug prices are too high and the government needs to use a bidding system to determine the price of drugs.  The sell off in pharma stocks was because Wall Street has finally realized the “gravy train” is coming to an end. Continue reading

Older Americans paying the price for brand name prescription drugs

KEY TAKEAWAY:Retail prices for widely used brand name prescription drugs increased substantially faster than general inflation in every year from 2006 to 2015. Between 2014 and 2015, retail prices for 268 brand name prescription drugs widely used by older Americans, including Medicare beneficiaries, increased by an average of 15.5 percent. In contrast, the general inflation rate was 0.1 percent over the same period. Continue reading

Pharma learns a hard political lesson

KEY TAKEAWAY: Shares of biotechnology and pharmaceutical companies retreated after President-elect Donald Trump vowed in a magazine article to crack down on drug prices. Drug stocks fell after Mr. Trump was quoted in a Time Person of the Year article as saying: “I’m going to bring down drug prices.”  Better put that champagne on ice. Continue reading